CYCN
Cyclerion Therapeutics
$3.50
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame CYCN today
- Market cap
- $15.16M
- P/E (TTM)
- -2.9
- EV / FCF
- -3.4
- Gross margin
- 100%
- EV / Sales
- 6.2
- ROIC
- -103.7%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.03
- 52wk High
- $8.48
Growth
Revenue and earnings trend for CYCN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CYCN
Is Cyclerion Therapeutics a good buy?
Hold. Cyclerion Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Cyclerion Therapeutics is selling at a very high price.
What is the market capitalization of CYCN?
Cyclerion Therapeutics's market capitalization is $15.16M.
What is the P/E ratio for CYCN stock?
Cyclerion Therapeutics's current P/E ratio is -2.9.
What is the 52-week high for CYCN stock?
The 52-week high for Cyclerion Therapeutics is $8.48. The current close of $3.50 is 58.7% below that high.
What is the 52-week low for CYCN stock?
The 52-week low for Cyclerion Therapeutics is $1.03. The current close of $3.50 is 240.8% above that low.
Does CYCN stock pay dividends?
Cyclerion Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CYCN?
Cyclerion Therapeutics's Debt / Equity ratio is 0.